A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation.

Autor: Turti TV; Scientific Center of Children's Health, RAMS, Lomonosovskiy Prospect, 2/62, Moscow, 119991, Russia. turtit@mail.ru, Baibarina EN, Degtiareva EA, Keshishyan ES, Lobzin YV, Namazova-Вaranova LS, Prodeus AP, Gudkov KM, Kruglova AI, Schulz GA, Notario GF

Publikováno v: BMC research notes [BMC Res Notes] 2012 Sep 04; Vol. 5, pp. 484. Date of Electronic Publication: 2012 Sep 04.